ImmunoGen, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ImmunoGen, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2023.
  • ImmunoGen, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $8.34M, a 22.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $8.34M -$2.47M -22.9% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $9M -$2.36M -20.8% Jun 30, 2023 10-Q 2023-07-31
Q1 2023 $9.63M -$2.26M -19% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $10.2M -$2.16M -17.4% Dec 31, 2022 10-Q 2023-11-02
Q3 2022 $10.8M -$1.94M -15.2% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $11.4M -$1.85M -14% Jun 30, 2022 10-Q 2022-08-01
Q1 2022 $11.9M -$1.76M -12.9% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $12.4M -$1.68M -11.9% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $12.7M -$1.73M -12% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $13.2M -$1.66M -11.2% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $13.6M -$1.59M -10.4% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $14.1M -$1.52M -9.72% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $14.5M -$1.45M -9.09% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $14.9M -$1.53M -9.31% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $15.2M -$1.47M -8.81% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 $15.6M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $15.9M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $16.4M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $16.7M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.